[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Selective Cox-2 Inhibitors Market Status, Trends and COVID-19 Impact Report 2021

March 2022 | 122 pages | ID: GC7549125484EN
BisReport Information Consulting CO., Ltd

US$ 2,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In the past few years, the Selective Cox-2 Inhibitors market experienced a huge change under the influence of COVID-19, the global market size of Selective Cox-2 Inhibitors reached (2021 Market size XXXX) million $ in 2021 from (2016 Market size XXXX) in 2016 with a CAGR of XXX from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases have exceeded 200 million, and the global epidemic has been basically under control, therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The World Bank predicts that the global economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research on Selective Cox-2 Inhibitors market and global economic environment, we forecast that the global market size of Selective Cox-2 Inhibitors will reach (2026 Market size XXXX) million $ in 2026 with a CAGR of % from 2021-2026.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to recover and partially adapted to pandemic restrictions. The research and development of vaccines has made breakthrough progress, and many governments have also issued various policies to stimulate economic recovery, particularly in the United States, is likely to provide a strong boost to economic activity but prospects for sustainable growth vary widely between countries and sectors. Although the global economy is recovering from the great depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged period. The pandemic has exacerbated the risks associated with the decade-long wave of global debt accumulation. It is also likely to steepen the long-expected slowdown in potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic environment, we published the Global Selective Cox-2 Inhibitors Market Status, Trends and COVID-19 Impact Report 2021, which provides a comprehensive analysis of the global Selective Cox-2 Inhibitors market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type wise, industry wise, channel wise etc. all the data period is from 2015-2021E, this report also provide forecast data from 2021-2026.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Meda Pharmaceuticals
Cipla
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
Almirall Limited
Lupin Pharmaceuticals
Aurobindo Pharma
Pfizer
Mylan
Shire Pharmaceuticals
Bayer
Novacap
Abbott
Geri-Care
Perrigo
Kopran
Merck
Hengrui pharmaceutical
Kelun Group
Qilu Pharmaceutical
Taro Pharmaceuticals 

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
Meloxicam
Celecoxib
Etoricoxib
Imrecoxib
Etodolac

Application Segmentation
Rheumatoid Arthritis
Osteoarthritis
Spondylosis Chronica Ankylopoietica

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2021-2026)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source

SECTION 1 SELECTIVE COX-2 INHIBITORS MARKET OVERVIEW

1.1 Selective Cox-2 Inhibitors Market Scope
1.2 COVID-19 Impact on Selective Cox-2 Inhibitors Market
1.3 Global Selective Cox-2 Inhibitors Market Status and Forecast Overview
  1.3.1 Global Selective Cox-2 Inhibitors Market Status 2016-2021
  1.3.2 Global Selective Cox-2 Inhibitors Market Forecast 2021-2026

SECTION 2 GLOBAL SELECTIVE COX-2 INHIBITORS MARKET MANUFACTURER SHARE

2.1 Global Manufacturer Selective Cox-2 Inhibitors Sales Volume
2.2 Global Manufacturer Selective Cox-2 Inhibitors Business Revenue

SECTION 3 MANUFACTURER SELECTIVE COX-2 INHIBITORS BUSINESS INTRODUCTION

3.1 Boehringer-Ingelheim Selective Cox-2 Inhibitors Business Introduction
  3.1.1 Boehringer-Ingelheim Selective Cox-2 Inhibitors Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.1.2 Boehringer-Ingelheim Selective Cox-2 Inhibitors Business Distribution by Region
  3.1.3 Boehringer-Ingelheim Interview Record
  3.1.4 Boehringer-Ingelheim Selective Cox-2 Inhibitors Business Profile
  3.1.5 Boehringer-Ingelheim Selective Cox-2 Inhibitors Product Specification
3.2 TerSera Therapeutics Selective Cox-2 Inhibitors Business Introduction
  3.2.1 TerSera Therapeutics Selective Cox-2 Inhibitors Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.2.2 TerSera Therapeutics Selective Cox-2 Inhibitors Business Distribution by Region
  3.2.3 Interview Record
  3.2.4 TerSera Therapeutics Selective Cox-2 Inhibitors Business Overview
  3.2.5 TerSera Therapeutics Selective Cox-2 Inhibitors Product Specification
3.3 Manufacturer three Selective Cox-2 Inhibitors Business Introduction
  3.3.1 Manufacturer three Selective Cox-2 Inhibitors Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.3.2 Manufacturer three Selective Cox-2 Inhibitors Business Distribution by Region
  3.3.3 Interview Record
  3.3.4 Manufacturer three Selective Cox-2 Inhibitors Business Overview
  3.3.5 Manufacturer three Selective Cox-2 Inhibitors Product Specification

SECTION 4 GLOBAL SELECTIVE COX-2 INHIBITORS MARKET SEGMENTATION (BY REGION)

4.1 North America Country
  4.1.1 United States Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.1.2 Canada Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.1.3 Mexico Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
4.2 South America Country
  4.2.1 Brazil Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.2.2 Argentina Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
  4.3.1 China Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.3.2 Japan Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.3.3 India Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.3.4 Korea Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.3.5 Southeast Asia Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
4.4 Europe Country
  4.4.1 Germany Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.4.2 UK Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.4.3 France Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.4.4 Spain Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.4.5 Italy Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
  4.5.1 Africa Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
  4.5.2 Middle East Selective Cox-2 Inhibitors Market Size and Price Analysis 2016-2021
4.6 Global Selective Cox-2 Inhibitors Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Selective Cox-2 Inhibitors Market Segmentation (By Region) Analysis

SECTION 5 GLOBAL SELECTIVE COX-2 INHIBITORS MARKET SEGMENTATION (BY PRODUCT TYPE)

5.1 Product Introduction by Type
  5.1.1 Meloxicam Product Introduction
  5.1.2 Celecoxib Product Introduction
  5.1.3 Etoricoxib Product Introduction
  5.1.4 Imrecoxib Product Introduction
  5.1.5 Etodolac Product Introduction
5.2 Global Selective Cox-2 Inhibitors Sales Volume by Celecoxib016-2021
5.3 Global Selective Cox-2 Inhibitors Market Size by Celecoxib016-2021
5.4 Different Selective Cox-2 Inhibitors Product Type Price 2016-2021
5.5 Global Selective Cox-2 Inhibitors Market Segmentation (By Type) Analysis

SECTION 6 GLOBAL SELECTIVE COX-2 INHIBITORS MARKET SEGMENTATION (BY APPLICATION)

6.1 Global Selective Cox-2 Inhibitors Sales Volume by Application 2016-2021
6.2 Global Selective Cox-2 Inhibitors Market Size by Application 2016-2021
6.2 Selective Cox-2 Inhibitors Price in Different Application Field 2016-2021
6.3 Global Selective Cox-2 Inhibitors Market Segmentation (By Application) Analysis

SECTION 7 GLOBAL SELECTIVE COX-2 INHIBITORS MARKET SEGMENTATION (BY CHANNEL)

7.1 Global Selective Cox-2 Inhibitors Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Selective Cox-2 Inhibitors Market Segmentation (By Channel) Analysis

SECTION 8 SELECTIVE COX-2 INHIBITORS MARKET FORECAST 2021-2026

8.1 Selective Cox-2 Inhibitors Segmentation Market Forecast 2021-2026 (By Region)
8.2 Selective Cox-2 Inhibitors Segmentation Market Forecast 2021-2026 (By Type)
8.3 Selective Cox-2 Inhibitors Segmentation Market Forecast 2021-2026 (By Application)
8.4 Selective Cox-2 Inhibitors Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Selective Cox-2 Inhibitors Price Forecast

SECTION 9 SELECTIVE COX-2 INHIBITORS APPLICATION AND CLIENT ANALYSIS

9.1 Rheumatoid Arthritis Customers
9.2 Osteoarthritis Customers
9.3 Spondylosis Chronica Ankylopoietica Customers

SECTION 10 SELECTIVE COX-2 INHIBITORS MANUFACTURING COST OF ANALYSIS

11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

SECTION 11 CONCLUSION

SECTION 12 METHODOLOGY AND DATA SOURCE

CHART AND FIGURE

Figure Selective Cox-2 Inhibitors Product Picture
Chart Global Selective Cox-2 Inhibitors Market Size (with or without the impact of COVID-19)
Chart Global Selective Cox-2 Inhibitors Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Selective Cox-2 Inhibitors Market Size (Million $) and Growth Rate 2016-2021
Chart Global Selective Cox-2 Inhibitors Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Selective Cox-2 Inhibitors Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Selective Cox-2 Inhibitors Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Selective Cox-2 Inhibitors Sales Volume Share
Chart 2016-2021 Global Manufacturer Selective Cox-2 Inhibitors Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Selective Cox-2 Inhibitors Business Revenue Share
Chart Boehringer-Ingelheim Selective Cox-2 Inhibitors Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Boehringer-Ingelheim Selective Cox-2 Inhibitors Business Distribution
Chart Boehringer-Ingelheim Interview Record (Partly)
Chart Boehringer-Ingelheim Selective Cox-2 Inhibitors Business Profile
Table Boehringer-Ingelheim Selective Cox-2 Inhibitors Product Specification
Chart TerSera Therapeutics Selective Cox-2 Inhibitors Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart TerSera Therapeutics Selective Cox-2 Inhibitors Business Distribution
Chart TerSera Therapeutics Interview Record (Partly)
Chart TerSera Therapeutics Selective Cox-2 Inhibitors Business Overview
Table TerSera Therapeutics Selective Cox-2 Inhibitors Product Specification
Chart United States Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Canada Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Mexico Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Mexico Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Brazil Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Brazil Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Argentina Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Argentina Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart China Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Japan Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart India Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Korea Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Southeast Asia Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Southeast Asia Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Germany Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart UK Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart France Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Spain Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Spain Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Italy Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Africa Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Middle East Selective Cox-2 Inhibitors Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Selective Cox-2 Inhibitors Sales Price (USD/Unit) 2016-2021
Chart Global Selective Cox-2 Inhibitors Market Segmentation Sales Volume (Units) by Region 2016-2021
Chart Global Selective Cox-2 Inhibitors Market Segmentation Sales Volume (Units) Share by Region 2016-2021
Chart Global Selective Cox-2 Inhibitors Market Segmentation Market size (Million $) by Region 2016-2021
Chart Global Selective Cox-2 Inhibitors Market Segmentation Market size (Million $) Share by Region 2016-2021
Chart Meloxicam Product Figure
Chart Meloxicam Product Description
Chart Celecoxib Product Figure
Chart Celecoxib Product Description
Chart Etoricoxib Product Figure
Chart Etoricoxib Product Description
Chart Selective Cox-2 Inhibitors Sales Volume (Units) by Celecoxib016-2021
Chart Selective Cox-2 Inhibitors Sales Volume (Units) Share by Type
Chart Selective Cox-2 Inhibitors Market Size (Million $) by Celecoxib016-2021
Chart Selective Cox-2 Inhibitors Market Size (Million $) Share by Celecoxib016-2021
Chart Different Selective Cox-2 Inhibitors Product Type Price ($/Unit) 2016-2021
Chart Selective Cox-2 Inhibitors Sales Volume (Units) by Application 2016-2021
Chart Selective Cox-2 Inhibitors Sales Volume (Units) Share by Application
Chart Selective Cox-2 Inhibitors Market Size (Million $) by Application 2016-2021
Chart Selective Cox-2 Inhibitors Market Size (Million $) Share by Application 2016-2021
Chart Selective Cox-2 Inhibitors Price in Different Application Field 2016-2021
Chart Global Selective Cox-2 Inhibitors Market Segmentation (By Channel) Sales Volume (Units) 2016-2021
Chart Global Selective Cox-2 Inhibitors Market Segmentation (By Channel) Share 2016-2021
Chart Selective Cox-2 Inhibitors Segmentation Market Sales Volume (Units) Forecast (by Region) 2021-2026
Chart Selective Cox-2 Inhibitors Segmentation Market Sales Volume Forecast (By Region) Share 2021-2026
Chart Selective Cox-2 Inhibitors Segmentation Market Size (Million USD) Forecast (By Region) 2021-2026
Chart Selective Cox-2 Inhibitors Segmentation Market Size Forecast (By Region) Share 2021-2026
Chart Selective Cox-2 Inhibitors Market Segmentation (By Type) Volume (Units) 2021-2026
Chart Selective Cox-2 Inhibitors Market Segmentation (By Type) Volume (Units) Share 2021-2026
Chart Selective Cox-2 Inhibitors Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Selective Cox-2 Inhibitors Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Selective Cox-2 Inhibitors Market Segmentation (By Application) Market Size (Volume) 2021-2026
Chart Selective Cox-2 Inhibitors Market Segmentation (By Application) Market Size (Volume) Share 2021-2026
Chart Selective Cox-2 Inhibitors Market Segmentation (By Application) Market Size (Value) 2021-2026
Chart Selective Cox-2 Inhibitors Market Segmentation (By Application) Market Size (Value) Share 2021-2026
Chart Global Selective Cox-2 Inhibitors Market Segmentation (By Channel) Sales Volume (Units) 2021-2026
Chart Global Selective Cox-2 Inhibitors Market Segmentation (By Channel) Share 2021-2026
Chart Global Selective Cox-2 Inhibitors Price Forecast 2021-2026
Chart Rheumatoid Arthritis Customers
Chart Osteoarthritis Customers
Chart Spondylosis Chronica Ankylopoietica Customers


More Publications